In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center ...

Precision BioSciences reports early PBGENE-HBV trial data showing safety and antiviral activity in chronic Hepatitis B patients, with more results expected in 2025.

Assessment of liver fibrosis and cirrhosis is crucial for the management of patients with chronic hepatitis B. The presence of at least moderate liver fibrosis is an important indication for antiviral ...

The NHS will automatically test patients for HIV, Hepatitis B and Hepatitis C unless they ... money sense for the NHS" as it allows early treatment, which stops HIV progressing, preventing severe ...

GSK has revealed updated results from its phase 2b trial of its antisense drug for hepatitis B virus (HBV ... undetectable after stopping all treatment. In B-Clear, patients with low baseline ...

The "Clinical Snapshot" series provides a concise examination of a clinical presentation including history, treatment, patient education, and nursing ... associated with hepatitis C and all ...

A total of 118 recommendations based on expert consensus were published regarding the treatment of hidradenitis suppurativa in 7 specific patient populations.

Dynavax reports record HEPLISAV-B revenue, 26% growth in 2024, and strong 2025 guidance. Insights on shingles vaccine progress & market expansion.

With several drugs in use that inhibit the hepatitis B virus polymerases (nucleos(t)ide analogues (or NUCs)), some argue that new direct-acting antiviral drugs, and new NUCs in particular ...

Nov. 21, 2024 — Scientists have discovered how long-term treatment of high blood pressure with commonly prescribed drugs can destroy the kidney's ability to filter and purify blood. The finding ...